Zobrazeno 1 - 6
of 6
pro vyhledávání: '"CVRF, cardiovascular risk factors"'
Autor:
Claudio Gonzalez, R. Ravi Shankar, Paul Keown, Kristy Iglay, Kimberly G. Brodovicz, Shengsheng Yu, Rosario Arechavaleta, Kaan Tunceli, Olaf Heisel, Freddy Goldberg Eliaschewitz, Juan José Gagliardino
Publikováno v:
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology, Vol 15, Iss, Pp 76-80 (2019)
Journal of Clinical & Translational Endocrinology, Vol 15, Iss, Pp 76-80 (2019)
Objective: To assess oral antihyperglycemic agents (OAHA) and/or statin treatment initiation in patients with type 2 diabetes (T2D) and time from diagnosis to both types of treatment initiation and intensification. Research design and methods: We rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad541affb4db5d2206502cb7a99406d7
https://doi.org/10.1016/j.jcte.2019.01.002
https://doi.org/10.1016/j.jcte.2019.01.002
Publikováno v:
Journal of Advanced Research
Graphical abstract
Introduction Recently, Nrf2/HO-1 has received extensive attention as the main regulatory pathway of intracellular defense against oxidative stress and is considered an ideal target for alleviating endothelial cell (EC) injury.
Introduction Recently, Nrf2/HO-1 has received extensive attention as the main regulatory pathway of intracellular defense against oxidative stress and is considered an ideal target for alleviating endothelial cell (EC) injury.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9de6be7acea23fd93887832ef07452a1
https://pubmed.ncbi.nlm.nih.gov/35024180
https://pubmed.ncbi.nlm.nih.gov/35024180
Autor:
Kathleen M. McTigue, Rolf Loeber, Stephanie D. Stepp, Charity G. Moore, Lewis H. Kuller, Alison E. Hipwell, Elan D. Cohen
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 2, Iss 4, Pp 150-156 (2015)
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology
Highlights • Youth-onset severe obesity warrants particular concern in urban female populations. • Among 2226 girls, prevalence was 8.3% at age 7–10, 10.8% at age 12–15 and fairly stable over teen years. • Severe obesity prevalence increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc6ee1a15d06e305c63e031f4ed2ac1
http://www.sciencedirect.com/science/article/pii/S221462371500054X
http://www.sciencedirect.com/science/article/pii/S221462371500054X
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhang Q; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611130, PR China., Liu J; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611130, PR China., Duan H; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611130, PR China., Li R; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611130, PR China., Peng W; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611130, PR China., Wu C; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611130, PR China.
Publikováno v:
Journal of advanced research [J Adv Res] 2021 Jul 06; Vol. 34, pp. 43-63. Date of Electronic Publication: 2021 Jul 06 (Print Publication: 2021).
Autor:
José Gagliardino J; CENEXA, Centro de Endocrinología Experimental y Aplicada (UNLP-CONICET La Plata), La Plata, Argentina., Arechavaleta R; Department of Endocrinology, Universidad Autonoma de Guadalajara, Guadalajara, Mexico., Goldberg Eliaschewitz F; CPClin Clinical Research Center, São Paulo, Brazil., Iglay K; Merck & Co., Inc., Kenilworth, NJ, USA., Brodovicz K; Merck & Co., Inc., Kenilworth, NJ, USA., Gonzalez CD; MSD-Argentina, Buenos Aires, Argentina., Yu S; Merck & Co., Inc., Kenilworth, NJ, USA., Ravi Shankar R; Merck & Co., Inc., Kenilworth, NJ, USA., Heisel O; Syreon Corporation, Vancouver, British Columbia, Canada., Keown P; Syreon Corporation, Vancouver, British Columbia, Canada., Tunceli K; Merck & Co., Inc., Kenilworth, NJ, USA.
Publikováno v:
Journal of clinical & translational endocrinology [J Clin Transl Endocrinol] 2019 Jan 25; Vol. 15, pp. 76-80. Date of Electronic Publication: 2019 Jan 25 (Print Publication: 2019).